
BioLM is an AI company focused on accelerating biological workflows for biotech and life science companies. They specialize in lead optimization, candidate selection and testing, and closing the loop in R&D by creating and validating molecules using machine learning. BioLM offers both professional services, including custom AI workflow development and model fine-tuning, and a SaaS platform for experts to access their infrastructure. Their team has extensive experience in both dry lab and wet lab environments, with a focus on biological data modeling. They have partnered with companies like Caravel Bio and Rhea's Factory, achieving significant improvements in catalyst productivity and enzyme selection.

BioLM is an AI company focused on accelerating biological workflows for biotech and life science companies. They specialize in lead optimization, candidate selection and testing, and closing the loop in R&D by creating and validating molecules using machine learning. BioLM offers both professional services, including custom AI workflow development and model fine-tuning, and a SaaS platform for experts to access their infrastructure. Their team has extensive experience in both dry lab and wet lab environments, with a focus on biological data modeling. They have partnered with companies like Caravel Bio and Rhea's Factory, achieving significant improvements in catalyst productivity and enzyme selection.
Founded: 2022
Headquarters: Oakland, United States
Focus: Bio-AI platform and services for protein/DNA sequence & structure modeling
Product types: Hosted APIs, GPU-accelerated models, Python SDK, SaaS plans and professional services
Known investor: 2048 Ventures (seed, Mar 2023)
Accelerating R&D workflows in biotechnology by automating sequence/structure prediction, design, and validation to improve lead optimization and candidate selection.
2022
Biotechnology
Listed as Seed participation in March 2023
“2048 Ventures participation in a March 2023 seed round as reported by Dealroom”